(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

UNIFERON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

UNIFERON

ST13

US500000079029508

Class

5

Filing

79029508

Registration

3307559

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

05/16/2025

Trademark type

Word

Nice classes

5

Filing date

09/27/2006

Registration date

10/09/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/28/2017

Last transaction

05/16/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DK

Examiner

PILARO, MARK F

Law office

L40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Pharmacosmos Holding A/S
Pharmacosmos A/S

Representatives

Josh A. Partington HARNESS, DICKEY & PIERCE, PLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Iron preparations for pharmaceutical and veterinary use in the treatment of anemiaas well as iron preparations as food supplements

Publications

History of USPTO decisions and trademark events.

42 publications found

RNWL

INTERNATIONAL REGISTRATION RENEWED

05/15/2025

CHLD

CHANGE OF OWNER RECEIVED FROM IB

07/29/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/23/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/02/2017

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/28/2017

71AG

REGISTERED-SEC.71 ACCEPTED

07/28/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/28/2017

ES71

TEAS SECTION 71 RECEIVED

07/07/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/02/2017

CHLD

CHANGE OF OWNER RECEIVED FROM IB

07/23/2015

RNWL

INTERNATIONAL REGISTRATION RENEWED

06/25/2015

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/15/2013

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED

11/16/2012

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

11/16/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/16/2012

715F

REGISTERED - SEC. 71 & SEC. 15 FILED

10/18/2012

ES75

TEAS SECTION 71 & 15 RECEIVED

10/18/2012

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/13/2008

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/24/2008

FIMP

FINAL DISPOSITION PROCESSED

01/24/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/16/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

10/09/2007

PUBO

PUBLISHED FOR OPPOSITION

07/24/2007

NPUB

NOTICE OF PUBLICATION

07/04/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/19/2007

ALIE

ASSIGNED TO LIE

06/15/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/15/2007

CNEA

EXAMINERS AMENDMENT MAILED

06/13/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

06/13/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/13/2007

ACEC

AMENDMENT FROM APPLICANT ENTERED

05/16/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/16/2007

ALIE

ASSIGNED TO LIE

05/16/2007

FAXX

FAX RECEIVED

04/23/2007

RFNT

REFUSAL PROCESSED BY IB

03/15/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/28/2007

RFRR

REFUSAL PROCESSED BY MPU

02/28/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/28/2007

CNRT

NON-FINAL ACTION WRITTEN

02/27/2007

DOCK

ASSIGNED TO EXAMINER

02/15/2007

NWAP

NEW APPLICATION ENTERED

11/03/2006

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

11/02/2006

Continuous trademark protection

Get notified about every new filing that threatens UNIFERON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.